Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
Go back to Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.88 -0.08 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.96 | 52 Week High | $59.00 | |||
| Open | $43.94 | 52 Week Low | $32.80 | |||
| Day High | $44.60 | P/E | N/A | |||
| Day Low | $43.72 | EPS | $0.00 | |||
| Volume | 14,796,982 | |||||
